MINI REVIEW article
Front. Pharmacol.
Sec. Neuropharmacology
Volume 16 - 2025 | doi: 10.3389/fphar.2025.1592650
Clinical characterization and management of persons with comorbid epilepsy and depression: an expert opinion paper
Provisionally accepted- 1University of Campania "L. Vanvitelli", Naples, Italy
- 2Catholic University of the Sacred Heart, Rome, Rome, Sicily, Italy
- 3Besta Neurosim Center, Department of Neurosurgery, IRCCS Carlo Besta Neurological Institute Foundation, Milano, Lombardy, Italy
- 4IRCCS Oasi Maria SS, Troina, Italy
- 5Magna Græcia University, Catanzaro, Calabria, Italy
- 6University of Genoa, Genoa, Liguria, Italy
- 7Siena University Hospital, Siena, Tuscany, Italy
- 8Marche Polytechnic University, Ancona, Marche, Italy
- 9San Martino Hospital (IRCCS), Genova, Liguria, Italy
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Introduction: Medical conditions related to the nervous system affects 3.4 billion individuals worldwide and are collectively ranked as the leading cause of disability-adjusted life years (DALYs). Epilepsy is listed among the ten conditions with the highest age standardized DALYs, while depression is expected to become the first cause of disability for mental disorders by 2030.Persons with epilepsy have a higher risk of developing depression, and vice versa. Epilepsy and depression both can influence individual's personal functioning, social activities and can increase the risk of sudden epileptic attacks. Depression is probably the most frequent psychiatric comorbidity reported in patients with epilepsy. Several studies have highlighted a bidirectional association between depression and epilepsy.The present mini-review is based on expert meetings held in the period May-September 2024. A panel of expert clinicians, working in the field of epilepsy and of clinical psychiatry have been invited to participate, due to their experience and expertise in the topic.Panel members, under the guidance of two senior experts, have identified the relevant topics to be analyzed, discussed and commented.Results: Included studies dealt with the historical perspective on epilepsy and depression; the complexity of diagnostic and clinical comorbidity between epilepsy and depression; the assessment tools for screening for depression in patients with epilepsy.The clinical condition of patients suffering from comorbid depression and epilepsy represents a challenge for neurologists and psychiatrists. Therefore, the management of comorbid epilepsy and depression requires a detailed clinical characterization of each individual case in order to develop an integrated and personalized management plan.
Keywords: Depression, Epilepsy, Comorbidity, Burden, differential diagnosis
Received: 14 Mar 2025; Accepted: 06 Jun 2025.
Copyright: © 2025 Sampogna, Brugnoli, Didato, Elia, Ferlazzo, Serafini, Vatti, Volpe, Villani and Sani. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Gaia Sampogna, University of Campania "L. Vanvitelli", Naples, Italy
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.